serine/arginine-Rich Splicing Factor 4 (SRSF4) (Middle Region) Peptide
SRSF4
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits SRSF4
- SRSF4 (serine/arginine-Rich Splicing Factor 4 (SRSF4))
- Protein Region
- Middle Region
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-SFRS4 antibody (Catalog #: ARP40592_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- SRSF4 (serine/arginine-Rich Splicing Factor 4 (SRSF4))
- Synonymes
- SFRS4 Peptide, SRP75 Peptide, 5730499P16Rik Peptide, AW550192 Peptide, MNCb-2616 Peptide, SRp75 Peptide, Sfrs4 Peptide, RGD1561347 Peptide, serine and arginine rich splicing factor 4 Peptide, serine/arginine-rich splicing factor 4 Peptide, SRSF4 Peptide, Srsf4 Peptide
- Sujet
-
SFRS4 is a member of the arginine/serine-rich splicing factor family. SFRS4 likely functions in mRNA processing.
Alias Symbols: SRP75, SFRS4
Protein Interaction Partner: PNN,FUS,HAP1,PNN,SFRS12,SIP1,SMURF1,SMURF2,SRPK1,SRSF2IP,SRSF6,DYRK1A,HAP1,PNN,PPARGC1A,SRRM1,SRSF6
Protein Size: 494 - Poids moléculaire
- 57 kDa
- ID gène
- 6429
- NCBI Accession
- NM_005626, NP_005617
- UniProt
- Q08170
-
Vous êtes ici:
